Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can the Investigators Extend the Indication for Sentinel Node Biopsy in Vulvar Cancer? A Nationwide Feasibility Study From Sweden

NCT04147780 is registered in ClinicalTrials.gov with Diana Zach as lead sponsor.

NCT NCT04147780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04147780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can the Investigators Extend the Indication for Sentinel Node Biopsy in Vulvar Cancer? A Nationwide Feasibility Study From Sweden
Lead sponsor
Diana Zach
Phase
Observational
Overall status
Completed
Start date
December 14, 2019
Completion date
February 15, 2023
Enrollment
64 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

sentinel lymph node, vulva cancer